Remote Director, Patient Safety Strategy

Boehringer Ingelheim; Ridgefield (CT); Remote; USD 265,000 - 397,000; Full time

Job summary

Boehringer Ingelheim is seeking a Director in Global Experimental Medicine Patient Safety to provide strategic medical safety leadership for investigational compounds across early clinical development, partnering with Clinical Development, Regulatory Affairs, Biostatistics, Epidemiology and Global Pharmacovigilance.

The role shapes safety strategy for first‑in‑human and proof‑of‑concept studies, influences cross‑functional governance, and guides programs through complex medical and scientific

Qualifications

• US MD or DO degree; ophthalmology residency preferred.
• Total experience 5+ years incl. pharmaceutical safety or related fields.
• Ability to synthesize complex clinical data into benefit-risk conclusions.
• Knowledge of global pharmacovigilance requirements and regulatory compliance.

Responsibilities

• Lead medical safety strategy for investigational compounds across early development.
• Provide safety leadership for first-in-human, dose-escalation and proof-of-concept studies; review protocols and safety documents.
• Integrate diverse evidence to identify and communicate safety risks impacting development strategy.
• Define risk-management measures and contribute to governance and regulatory interactions.
• Oversee ongoing safety surveillance, signal evaluation, and regulatory input including DSURs.
• Represent Safety in internal/external forums and influence matrix teams and initiatives.

Skills

Medical safety leadership

Pharmacovigilance

Cross-functional leadership

Risk management

Regulatory collaboration

Global program governance

Education

MD or DO

Ophthalmology residency training

Job description

Boehringer Ingelheim is seeking a Director in Global Experimental Medicine Patient Safety to provide strategic medical safety leadership for investigational compounds across early clinical development, partnering with Clinical Development, Regulatory Affairs, Biostatistics, Epidemiology and Global Pharmacovigilance.

The role shapes safety strategy for first‑in‑human and proof‑of‑concept studies, influences cross‑functional governance, and guides programs through complex medical and scientific